Cardiovascular diseases ****************************************************************************************** * Cardiovascular diseases ****************************************************************************************** The research of cardiovascular diseases at the faculties of Charles University has a long 1930, Otto Klein from the Faculty of Medicine in Prague published his unique cardiac outpu results in 11 patients.  It was the world’s first diagnostic cardiac catheterisation in hu tradition continues today – the invasive cardiology area, including hemodynamic and therap interventions is still the most successful area of cardiovascular research at CU. The high of the European Society of Cardiology in 2014 – the Gold Medal was awarded to Petr Widimsk research results in the field of transcatheter treatment of myocardial infarction. Other a of cardiovascular diseases at all Five Faculties of Medicine of the CU include: treatment and imaging techniques in coronary heart disease, cardiomyopathy and myocarditis hypertension, peripheral vascular disease, heart failure, arterial hypertension, preventiv invasive diagnostics and therapy, physiology and pathophysiology of pulmonary circulation, syndromes and thrombosis, reperfusion therapy of acute strokes, new technologies in interv cardiology, surgical and interventional treatment of arrhythmias and new biological marker factors and pharmacological and non?pharmacological treatment. The research thus effectively covers the entire spectrum of cardiovascular diseases, and a of Medicine are involved, which cooperate on many projects (e.g. the internationally uniqu clinical trials “PRAGUE”). ****************************************************************************************** * Selected outputs ****************************************************************************************** • Widimsky P, Koznar B, Peisker T, Vasko P, Vavrova J, Stetkarova I. Direct catheter-based in acute ischaemic stroke performed collaboratively by cardiologists, neurologists and r single-centre pilot experience (PRAGUE-16 study). EuroIntervention. 2014 Nov;10(7):869-7 • Rosa J, Widimský P, Toušek P, et al. Randomized comparison of renal denervation versus i pharmacotherapy including spironolactone in true-resistant hypertension: six-month resul prague-15 study. Hypertension. 2015 Feb;65(2):407-13 • Kočka V, Malý M, Toušek P, Buděšínský T, Lisa L, Prodanov P, Jarkovský J, Widimský P.Bio vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective mu 'Prague 19'. Eur Heart J. 2014 Mar;35(12):787-94 • Budera P, Straka Z, Osmančík P, Vaněk T, Jelínek S, Hlavička J, Fojt R, Červinka P, Hulm Šmíd M, Malý M, Widimský P. Comparison of cardiac surgery with left atrial surgical abla cardiac surgery without atrial ablation in patients with coronary and/or valvular heart atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study. Eur He Nov;33(21):2644-52. (IF 10,478) • Veselka J, Krejčí J, Tomašov P, Zemánek D. Long-term survival after alcohol septal ablat for hypertrophic obstructive cardiomyopathy: a comparison with general population. Eur H 2014;35:2040-5. • Stěrba M, Popelová O, Vávrová A, Jirkovský E, Kovaříková P, Geršl V, Simůnek T. Oxidativ signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardi Antioxid Redox Signal. 2013 Mar 10;18(8):899-929. doi: 10.1089/ars.2012.4795. IF 7,667